Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate

T. Z. Aziz, D. Peggs, M. A. Sambrook, A. R. Crossman

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Central to the neural mechanism of MPTP-induced parkinsonism is overactivity of the subthalamic nucleus. Lesion of the subthalamic nucleus has therefore been performed in two primates with this condition and found to produce a remarkable amelioration of the disorder.
    Original languageEnglish
    Pages (from-to)288-292
    Number of pages4
    JournalMovement Disorders
    Volume6
    Issue number4
    DOIs
    Publication statusPublished - 1991

    Keywords

    • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    • Animals
    • Brain Mapping
    • drug effects: Dominance, Cerebral
    • Macaca fascicularis
    • Neurologic Examination
    • chemically induced: Parkinson Disease, Secondary
    • Radiosurgery
    • physiopathology: Thalamic Nuclei

    Fingerprint

    Dive into the research topics of 'Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate'. Together they form a unique fingerprint.

    Cite this